Skip to main content

Condition · 4 treatment paths

Lung Cancer

Lung cancer is a cancer that starts in the cells of the lung, mainly divided into non-small cell and small cell types. Smoking is the leading cause, though it also occurs in non-smokers.

Severe

Send your imaging + plan. Board-reviewed opinion in 5–10 working days.

Last updated: How we source & review

Linear accelerator used for radiotherapy in a cancer treatment room
Treatment paths
4Treatment paths
Specialties
1Specialties
Typical severity
SevereTypical severity

About lung cancer

What to know

Symptoms include a persistent cough, coughing up blood, breathlessness, chest pain, weight loss and repeated chest infections, though early disease may cause none. Diagnosis involves chest X-ray or CT, biopsy and molecular testing, with PET-CT and other scans for staging. Outcomes depend strongly on the stage at diagnosis.

Early non-small cell cancer is treated with surgery, usually lobectomy, or with stereotactic radiotherapy such as CyberKnife when surgery is not suitable. Locally advanced disease uses chemotherapy with radiation (IMRT). Advanced disease is treated with chemotherapy, targeted drugs for specific mutations and immunotherapy. Small cell cancer relies mainly on chemotherapy and radiotherapy. Treatment abroad is sometimes considered for advanced surgical or radiation technology.

Pre-flight workup

Tests to have already done

  • Biopsy pathology report with exact type (such as adenocarcinoma, squamous or small cell).
  • Molecular testing results including EGFR, ALK, ROS1, KRAS and PD-L1, which decide targeted therapy and immunotherapy.
  • CT chest and abdomen, PET-CT and brain MRI, which establish the stage.
  • Lung function tests and heart assessment, to judge whether you can safely have surgery or radiotherapy.
  • Details of any treatment already given, with dates, drugs and response scans.

Second opinion

When to get a second look

  • Your molecular tests were not done, or only a limited panel was used, so targeted options are uncertain.
  • Surgery has been ruled out and you want a thoracic surgeon and radiation oncologist to review your scans.
  • A very small early tumour has been found and you want to compare surgery with stereotactic radiotherapy.
  • The cancer has progressed on treatment and you want to hear about next-line or clinical trial options.

Talking to your doctor

Questions to ask

  1. What type and stage is my lung cancer, and have molecular tests been done?
  2. Is treatment aimed at cure, or at controlling the disease?
  3. Am I suitable for surgery, stereotactic radiotherapy, or drug treatment?
  4. Would a targeted drug or immunotherapy be appropriate, and what are the side effects?
  5. How will we know if treatment is working, and what happens if it stops?
  6. How can I stop smoking and manage my breathing during treatment?

Outlook

Realistic prognosis

Outlook depends heavily on stage and type. Early-stage non-small cell cancer treated with surgery or stereotactic radiotherapy can be cured in many patients. Advanced disease is rarely curable, but targeted drugs and immunotherapy have extended survival considerably, particularly with EGFR, ALK or high PD-L1 profiles. Small cell lung cancer is aggressive but often responds to initial treatment. Stopping smoking improves results.

Diagnostic workup

Before you pick a hospital, get the workup right

Severe — workup typically within 48–72 hours

Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.

  1. Confirm the diagnosis on imaging or labs

    For lung cancer, plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.

  2. See a oncology specialist locally first

    An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.

  3. Send us the file for a free second opinion

    Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.

  4. Pick a path with timeline + cost in writing

    Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.

04 · FAQ

Common questions about lung cancer

Do I need a biopsy and gene tests?

Yes, a tissue diagnosis is needed, and molecular tests (EGFR, ALK, ROS1 and PD-L1) decide whether targeted drugs or immunotherapy can be used.

Can lung cancer be cured?

Early-stage disease can often be cured with surgery or stereotactic radiotherapy. Advanced disease is usually treated for control, though modern drugs help many people live much longer.

Can non-smokers get lung cancer?

Yes. Adenocarcinoma with EGFR or ALK changes is common in non-smokers, and air pollution, radon and family history contribute.

Clinical context

Working up lung cancer properly

A condition like lung cancer is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.

Diagnostic workup, in sequence

  1. First-line clinical assessment

    History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.

  2. Standard imaging + labs

    Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.

  3. Specialist diagnostic workup

    Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.

  4. Multidisciplinary review (where indicated)

    Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.

When to escalate urgently

  • Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
  • Loss of consciousness, severe persistent vomiting, or any focal neurological event.
  • Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
  • If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.

Before you book international travel

  • Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
  • Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
  • Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
  • Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
  • Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
How this page is made

Methodology and editorial standards

This lung cancer overview is written by the editorial team from published Oncology sources and lists 4 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.

  1. Hospital data. Hospital details are compiled from public sources and hospital websites. Accreditation (JCI, NABH and others) is shown where we hold a record of it. Always ask the hospital for its current certificate.
  2. Doctor credentials. Qualifications, specialty and bio come from the doctor's hospital profile. Licence is checked against the national medical-council register only where the profile shows a "Licence verified" badge with a date.
  3. Prices. Price ranges are indicative, compiled from hospital price lists and packages and shown with the date last updated. The hospital's written quote is what you pay against.
  4. Clinical text. Written by the Medcasts editorial team from published clinical sources. Unless a named reviewer is shown on the page, it has not been reviewed by a doctor.
  5. Independence. Hospitals cannot pay to change their position on our pages.
Data sources for this page
Peer-reviewed clinical guidelines (NCCN, ESMO, ESC, AHA, NICE — by indication)WHO ICD-11 condition classificationNational medical society treatment protocolsJCI accreditation registry

Next step · Lung Cancer

Free second opinion on your Lung case.

Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.